Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM)

Authors
Category Primary study
JournalAnnals of Oncology
Year 2016
This article has no abstract
Epistemonikos ID: f6d0905d4fddf325a22abc67e3d3fb03c6f564ca
First added on: Feb 08, 2025